Epidemiology of Hodgkin's disease: A review

Hematological Oncology

Volumn 22, Issue 1, 2004, Pages 11-26

  Cartwright, R A ^a   Watkins, Gillian ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

Epidemiology; Epstein Barr virus; Hodgkin's disease; IM; Viral involvement

Indexed keywords

CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CLINICAL FEATURE; ENVIRONMENTAL FACTOR; EPSTEIN BARR VIRUS; GENETIC SUSCEPTIBILITY; GEOGRAPHIC DISTRIBUTION; HISTOPATHOLOGY; HODGKIN DISEASE; HUMAN; IMMUNE DEFICIENCY; INFECTIOUS MONONUCLEOSIS; LIFESTYLE; OCCUPATIONAL EXPOSURE; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SEASONAL VARIATION; SOCIOECONOMICS; VIRUS INFECTION;

ADULT; CONTINENTAL POPULATION GROUPS; EPSTEIN-BARR VIRUS INFECTIONS; GENETIC PREDISPOSITION TO DISEASE; HIV INFECTIONS; HODGKIN DISEASE; HUMANS; INCIDENCE; INFECTIOUS MONONUCLEOSIS; LIFE STYLE; MAJOR HISTOCOMPATIBILITY COMPLEX; OCCUPATIONAL EXPOSURE; SEASONS;

EID: 2642565083     PISSN: 02780232     EISSN: None     Source Type: Journal    
DOI: 10.1002/hon.723     Document Type: Review

References (158)

1. IARC. Cancer Incidence in Five Continents, vol. VII. IARC Scientific Publications (no. 143): Lyon, 1997.
2. Correa FP, O'Connor GT. Epidemiological patterns of Hodgkin's disease. Int J Cancer 1971; 8: 192.
3. Macfarlane GJ, Evstifeeva T, Boyle P, et al. International patterns in the occurrence of Hodgkin's disease in children and young adult males. Int J Cancer 1995; 61: 165-169.
4. Hjalgrim H, Askling J, Pukkala E, et al. Incidence of Hodgkin's disease in Nordic countries. Lancet 2001; 358: 297-298.
5. Yeole BB, Jussawalla DJ. Descriptive epidemiology of lymphatic malignancies in Greater Bombay. Oncol Rep 1998; 5: 771-777.
6. Chen YT, Zheng T, Chou MC, et al. The increase of Hodgkin's disease incidence among young adults. Experience in Connecticut, 1935-1992. Cancer 1997; 79: 2209-2218.
7. Liu S, Semenciw R, Waters C, et al. Time trends and sex patterns in Hodgkin's disease incidence in Canada, 1970-1995. Can J Public Health 2000; 91: 188-192.
8. Cartwright R, McNally R, Roman E, et al. Incidence and time trends in Hodgkin's disease: from parts of the United Kingdom (1984-1993). Leuk Lymph 1998; 31: 367-377.
9. Cartwright R, Brincker H, Carli PM, et al. The rise in incidence of lymphomas in Europe 1985-1992. Eur J Cancer 1999; 35: 627-633.
10. Newell GR, Lynch HK, Gibeau JM, Spitz MR. Seasonal diagnosis of Hodgkin's disease among young adults. J Natl Cancer Inst 1985; 74: 53-56.
11. Douglas S, Cortina-Borja M, Cartwright RA. Seasonal variation in the incidence of Hodgkin's disease. Br J Haematol 1998; 103: 653-662.
12. Neilly IJ, Dawson AA, Bennett B, et al. Evidence for a seasonal variation in the presentation of Hodgkin's disease. Leuk Lymph 1995; 18: 325-328.
13. Vianna NJ, Greenwald P, Brady J, et al. Hodgkin's disease: cases with features of a community outbreak. Ann Intern Med 1972; 77: 169-180.
14. Alexander FE, McKinney PA, Williams J, et al. Epidemiological evidence for the 'two-disease hypothesis' in Hodgkin's disease. Int J Epidemiol 1991; 20: 354-361.
15. Mangoud A, Hillier VF, Leck I, et al. Space-time interaction in Hodgkin's disease in Greater Manchester. J Epidemiol Community Health 1985; 39: 58-62.
16. Gilman EA, McNally RJQ, Cartwright RA. Space-time clustering of Hodgkin's Disease in parts of the UK, 1984-1993. Leuk Lymph 1999; 36: 85-100.
17. Ross A, Davis S. Point pattern analysis of the spatial proximity of residences prior to diagnosis of persons with Hodgkin's disease. Am J Epidemiol 1990; 132: S53-S62.
18. Glaser SL. Spatial clustering of Hodgkin's disease in the San Francisco Bay area. Am J Epidemiol 1990; 132: S167-S177.
19. Abramson JH, Pridan H, Sacks M, et al. A case-control study of Hodgkin's disease in Israel. J Natl Cancer Inst 1978; 61: 307-314.
20. LeShan L, Marvin S, Lyerly O. Some evidence of a relationship between Hodgkin's disease and intelligence. Arch Gen Psychiatry 1959; 1: 447-479.
21. Cohen BM, Smetan HF, Miller RW. Hodgkin's disease: long survival in a study of 388 World War II army cases. Cancer 1964; 17: 856-866.
22. MacMahon B. Epidemiology of Hodgkin's disease. Cancer Res 1966; 26: 1189-1200.
23. HMSO. The Registrar General's Decennial Supplement, England & Wales. HMSO: London, 1971; 418-458.
24. Alexander FE, Ricketts TJ, McKinney PA, et al. Community lifestyle characteristics and incidence of Hodgkin's disease in young people. Int J Cancer 1991; 48: 10-14.
25. Gutensohn NM. Social class and age at diagnosis of Hodgkin's disease: new epidemiologic evidence for the 'two-disease hypothesis'. Cancer Treat Rep 1982; 66: 689-695.
26. Glaser SL, Clarke CA, Steams CB, et al. Age variation in Hodgkin's disease risk factors in older women: evidence from a population-based case-control study. Leuk Lymph 2001; 42: 997-1004.
27. DeLong ER, Maile MC, Grufferman S. Climate, socioeconomic status and Hodgkin's disease mortality in the United States. J Chronic Dis 1984; 37: 209-213.
28. Rosdahl N, Larsen SO, Clemmesen J. Hodgkin's disease in patients with previous infectious mononucleosis: 30 years' experience. Br Med J 1974; 2: 253-256.
29. Mueller N, Grufferman S. Epidemiology. In Hodgkin's Disease, Mauch PM, Armitage J, Diehl V, Hoppe R, Weiss LM (eds). Raven Press, Ltd.: New York, 1999.
30. Hjalgrim H, Askling J, Sorensen P, et al. Risk of Hodgkin's disease and other cancers after infectious mononucleosis. J Natl Cancer Inst 2000; 92: 1522-1528.
31. Alexander FE, Jarrett RF, Lawrence D, et al. Risk factors for Hodgkin's disease by Epstein-Barr virus (EBV) status: prior infection by EBV and other agents. Br J Cancer 2000; 82: 1117-1121.
32. Sleckman BG, Mauch PM, Ambinder RF, et al. Epstein-Barr virus in Hodgkin's disease: correlation of risk factors and disease characteristics with molecular evidence of viral infection. Cancer Epidemiol Biomarkers Prev 1998; 7: 960-967.
33. Magrath I. Editorial comment on detection of Epstein-Barr virus DNA in peripheral blood of paediatric patients with Hodgkin's disease by real-time polymerase chain reaction by Wagner and colleagues. Eur J Cancer 2001; 37: 1812-1815.
34. Magrath I. The pathogenesis of Burkitt's lymphoma. Adv Cancer Res 1990; 55: 133-270.
35. Raab-Traub N, Flynn K, Pearson G, et al. The differentiated form of nasopharyngeal carcinoma contains Epstein-Barr virus DNA. Int J Cancer 1987; 39: 25-29.
36. Alexander FE, Daniel CP, Armstrong AA, et al. Case clustering, Epstein-Barr virus Reed Sternberg cell status and herpes virus serology in Hodgkin's disease: results of a case-control study. Eur J Cancer 1995; 31A: 1479-1486.
37. Macak J, Habanec B, Fabian P. Detection of Epstein-Barr virus in Hodgkin's lymphoma (patients in the Czech Republic). Neoplasma 2000; 47: 156-161.
38. Flavell KJ, Biddulph JP, Constandinou CM, et al. Variation in the frequency of Epstein-Barr virus-associated Hodgkin's disease with age. Leukemia 2000; 14: 748-753.
39. Armstrong AA, Alexander FE, Cartwright R, et al. Epstein-Barr virus and Hodgkin's disease: further evidence for the three disease hypothesis. Leukemia 1998; 12: 1272-1276.
40. Grasser FA, Murray PG, Kremmer E, et al. Monoclonal antibodies directed against the Epstein-Barr virus-encoded nuclear antigen 1 (EBNA1): immunohistologic detection of EBNA1 in the malignant cells of Hodgkin's disease. Blood 1994; 84: 3792-3798.
41. Jarrett RF, Gallagher A, Jones DB, et al. Detection of Epstein-Barr virus genomes in Hodgkin's disease: relation to age. J Clin Pathol 1991; 44: 844-848.
42. Gulley ML, Eagan PA, Quintanilla-Martinez L, et al. Epstein-Barr virus DNA is abundant and monoclonal in the Reed-Sternberg cells of Hodgkin's disease: association with mixed cellularity subtype and Hispanic American ethnicity. Blood 1994; 83: 1595-1602.
43. Mueller N, Evans A, Harris NL, et al. Hodgkin's disease and Epstein-Barr virus. Altered antibody pattern before diagnosis. New Engl J Med 1989; 320: 689-695.
44. Vestlev PM, Pallesen G, Sandvej K, et al. Prognosis of Hodgkin's disease is not influenced by Epstein-Barr virus latent membrane protein. Int J Cancer 1992; 50: 670-671.
45. Khan G, Norton AJ, Slavin G. Epstein-Barr virus in Hodgkin disease. Relation to age and subtype. Cancer 1993; 71: 3124-3129.
46. Serraino D, Boschini A, Carrieri P, et al. Cancer risk among men with, or at risk of, HIV infection in southern Europe. AIDS 2000; 14: 553-539.
47. Franceschi S, Dal Maso L, La Vecchia C. Advances in the epidemiology of HIV-associated non-Hodgkin's lymphoma and other lymphoid neoplasms. Int J Cancer 1999; 83: 481-485.
48. Grulich AE, Wan X, Law MG, et al. Risk of cancer in people with AIDS. AIDS 1999; 13: 839-843.
49. Lazzi S, Ferrari F, Nyongo A, et al. HIV-associated malignant lymphomas in Kenya (Equatorial Africa). Hum Pathol 1998; 29: 1285-1289.
50. Parkin DM, Wabinga H, Nambooze S, et al. AIDS-related cancers in Africa: maturation of the epidemic in Uganda. AIDS 1999; 13: 2563-2570.
51. Chokunonga E, Levy LM, Bassett MT, et al. AIDS and cancer in Africa: the evolving epidemic in Zimbabwe. AIDS 1999; 13: 2583-2588.
52. Dolcetti R, Boiocchi M, Gloghini A, et al. Pathogenetic and histogenetic features of HIV-associated Hodgkin's disease. Eur J Cancer 2001; 37: 1276-1287.
53. Andrieu JM, Roithmann S, Tourani JM, et al. Hodgkin's disease during HIV1 infection: the French registry experience. French Registry of HIV-associated Tumors. Ann Oncol 1993; 4: 635-641.
54. Roithmann S, Tourani JM, Andrieu JM. Hodgkin's disease in HIV-infected intravenous drug abusers. New Engl J Med 1990; 323: 275-276.
55. Rubio R. Hodgkin's disease associated with human immunodeficiency virus infection. A clinical study of 46 cases. Cooperative Study Group of Malignancies Associated with HIV Infection of Madrid. Cancer 1994; 73: 2400-2407.
56. Salahuddin SZ, Ablashi DV, Markham PD, et al. Isolation of a new virus, HBLV, in patients with lymphoproliferative disorders. Science 1986; 234: 596.
57. Ablashi DV, Josephs SF, Buchbinder A, et al. Human B-lymphotropic virus (human herpes virus-6). J Virol Methods 1988; 21: 29.
58. Biberfeld P, Petren A, Eklund A, et al. Human herpesvirus-6 (HHV-6, HBLV) in sarcoidosis and lymphoproliferative disorders. J Virol Methods 1988; 21: 49.
59. Clark DA, Alexander FE, McKinney PA, et al. The seroepidemiology of human herpesvirus-6 (HHV-6) from a case-control study of leukaemia and lymphoma. Int J Cancer 1990; 45: 829-833.
60. Iyengar S, Levine PH, Ablashi D, et al. Sero-epidemiological investigations on human herpesvirus 6 (HHV-6) infections using a newly developed early antigen assay. Int J Cancer 1991; 49: 551.
61. Schmidt CA, Oettle H, Peng R, et al. Presence of human beta- and gamma-herpes virus DNA in Hodgkin's disease. Leuk Res 2000; 24: 865-870.
62. Gompels UA, Carrigan DR, Carss AL, et al. Two groups of human herpesvirus 6 identified by sequence analyses of laboratory strains and variants from Hodgkin's lymphoma and bone marrow transplant patients. J Gen Virol 1993; 74(Pt 4): 613-622.
63. Gledhill S, Gallagher A, Jones D, et al. Viral involvement in Hodgkin's disease: detection of clonal type A EBV genomes in tumour samples. Br J Cancer 1991; 64: 227-232.
64. Jarrett RF, Gledhill S, Qureshi F, et al. Identification of human herpesvirus 6-specific DNA sequences in two patients with non-Hodgkin's lymphoma. Leukemia 1988; 2: 496-502.
65. Josephs SF, Buchbinder A, Streicher HZ, et al. Detection of human B-lymphotropic virus (human herpes-virus 6) sequences in B cell lymphoma tissues of three patients. Leukemia 1988; 2: 132-135.
66. Milham S Jr. Hodgkin's Disease as an occupational disease of school teachers (letter). New Engl J Med 1974; 290: 1329.
67. Hoover R. Hodgkin's disease in school teachers (letter). New Engl J Med 1974; 291: 473.
68. Fonte R, Grigis L, Grigis P, et al. Chemicals and Hodgkin's disease. Lancet 1982; 2: 50.
69. Grufferman S, Duong T, Cole P. Occupation and Hodgkin's disease. J Natl Cancer Inst 1976; 57: 1193-1195.
70. Vianna NJ, Polan AK, Keogh MD, et al. Hodgkin's disease mortality among physicians. Lancet 1974; 20: 131-133.
71. Matanoski GM, Sartwell PE, Elliott EA. Letter: Hodgkin's disease mortality among physicians. Lancet 1975; i: 926-927.
72. Smith PG, Kinlen LJ, Doll R. Letter: Hodgkin's disease mortality among physicians. Lancet 1974; ii: 525.
73. Milham S Jr, Hesser JE. Hodgkin's disease in woodworkers. Lancet 1967; ii: 136-137.
74. Petersen GR, Milham S Jr. Hodgkin's disease mortality and occupational exposure to wood. J Natl Cancer Inst 1974; 53: 957-958.
75. Olsen J, Sabroe S. A follow-up study of non-retired and retired members of the Danish Carpenter/Cabinet Makers' Trade Union. Int J Epidemiol 1979; 8: 375-382.
76. Bernard SM, Cartwright RA, Darwin CM, et al. Hodgkin's disease: case control epidemiological study in Yorkshire. Br J Cancer 1987; 55: 85-90.
77. La Vecchia C, Negri E, D'Avanzo B, et al. Occupation and lymphoid neoplasms. Br J Cancer 1989; 60: 385-388.
78. Vianna NJ, Polan A. Lymphomas and occupational benzene exposure. Lancet 1979; 1: 1394-1395.
79. Sorahan T, Parkes HG, Veys CA, et al. Mortality in the British rubber industry 1946-85. Br J Ind Med 1989; 46: 1-10.
80. Kaplan SD. Update of a mortality study of workers in petroleum refineries. J Occup Med 1986; 28: 514-516.
81. Rushton L, Alderson MR. An epidemiological survey of eight oil refineries in Britain. Br J Ind Med 1981; 38: 225-234.
82. Wen CP, Tsai SP, McClellan WA, et al. Long-term mortality study of oil refinery workers. I. Mortality of hourly and salaried workers. Am J Epidemiol 1983; 118: 526-542.
83. Dagg TG, Satin KP, Bailey WJ, et al. An updated cause specific mortality study of petroleum refinery workers. Br J Ind Med 1992; 49: 203-212.
84. Lagorio S, Forastiere F, Iavarone I, et al. Mortality of filling station attendants. Scand J Work Environ Health 1994; 20: 331-338.
85. Schnatter AR, Katz AM, Nicolich MJ, et al. A retrospective mortality study among Canadian petroleum marketing and distribution workers. Environ Health Perspect 1993; 101(Suppl. 6): 85-99.
86. Rushton L, Alderson MR. Epidemiological survey of oil distribution centres in Britain. Br J Ind Med 1983; 40: 330-339.
87. Olin GR, Ahlbom A. The cancer mortality among Swedish chemists graduated during three decades. A comparison with the general population and with a cohort of architects. Environ Res 1980; 22: 154-161.
88. Benn RT, Mangood A, Smith A. Hodgkin's disease and occupational exposure to chemicals. Br Med J 1979; 2: 1143.
89. Olsson H, Brandt L. Occupational exposure to organic solvents and Hodgkin's disease in men. A case-referent study. Scand J Work Environ Health 1980; 6: 302-305.
90. Hardell L, Bengtsson NO. Epidemiological study of socioeconomic factors and clinical findings in Hodgkin's disease, and reanalysis of previous data regarding chemical exposure. Br J Cancer 1983; 48: 217-225.
91. Franceschi S, Bidoli E, La Vecchia C. Pregnancy and Hodgkin's disease. Int J Cancer 1994; 58: 465-466.
92. Fingerhut MA, Halperin WE, Marlow DA, et al. Cancer mortality in workers exposed to 2,3,7,8-tetrachlor-odibenzo-p-dioxin. New Engl J Med 1991; 324: 212-218.
93. Saracci R, Kogevinas M, Bertazzi PA, et al. Cancer mortality in workers exposed to chlorophenoxy herbicides and chlorophenols. Lancet 1991; 338: 1027-1032.
94. Hoar SK, Blair A, Holmes FF, et al. Agricultural herbicide use and risk of lymphoma and soft-tissue sarcoma. JAMA 1986; 256: 1141-1147.
95. Garland FC, Gorham ED, Garland CF. Hodgkin's disease in the US Navy. Int J Epidemiol 1987; 16: 367-372.
96. Adami J, Nyren R, Bergstrom R, et al. Smoking and the risk of leukemia, lymphoma, and multiple myeloma (Sweden). Cancer Causes Control 1998; 9: 49-56.
97. Miligi L, Seniori CA, Crosignani P, et al. Occupational, environmental, and life-style factors associated with the risk of hematolymphopoietic malignancies in women. Am J Ind Med 1999; 36: 60-69.
98. Stagnaro E, Ramazzotti V, Crosignani P, et al. Smoking and hematolymphopoietic malignancies. Cancer Causes Control 2001; 12: 325-334.
99. Paffenbarger RS Jr, Wing AL, Hyde RT. Characteristics in youth indicative of adult-onset Hodgkin's disease. J Natl Cancer Inst 1977; 58: 1489-1491.
100. Tavani A, La Vecchia C, Gallus S, et al. Red meat intake and cancer risk: a study in Italy. Int J Cancer 2000; 86: 425-428.
101. Tavani A, Pregnolato A, Negri E, et al. Diet and risk of lymphoid neoplasms and soft tissue sarcomas. Nutr Cancer 1997; 27: 256-260.
102. Chatenoud L, Tavani A, La Vecchia C, et al. Whole grain food intake and cancer risk. Int J Cancer 1998; 77: 24-28.
103. Olsson H, Olsson ML, Ranstam J. Late age at first full-term pregnancy as a risk factor for women with malignant lymphoma. Neoplasma 1990; 37: 185-190.
104. Kravdal O, Hansen S. Hodgkin's disease: the protective effect of childbearing. Int J Cancer 1993; 55: 909-914.
105. Lambe M, Hsieh C, Tsaih S, et al. Childbearing and the risk of Hodgkin's disease. Cancer Epidemiol Biomarkers Prev 1998; 7: 831-834.
106. Razis DV, Diamond HD, Craver LF. Familial Hodgkin's disease: its significance and implications. Ann Intern Med 1959; 51: 933-971.
107. Grufferman S. Clustering and aggregation of exposures in Hodgkin's disease. Cancer 1977; 39: 1829-1833.
108. Kerzin-Storrar L, Faed MJ, MacGillivray JB, et al. Incidence of familial Hodgkin's disease. Br J Cancer 1983; 47: 707-712.
109. Haim N, Cohen Y, Robinson E. Malignant lymphoma in first-degree blood relatives. Cancer 1982; 49: 2197-2200.
110. Grufferman S, Cole P, Smith PG, et al. Hodgkin's disease in siblings. New Engl J Med 1977; 296: 248-250.
111. Ferraris AM, Racchi O, Rapezzi D, et al. Familial Hodgkin's disease: a disease of young adulthood? Ann Hematol 1997; 74: 131-134.
112. Vianna NJ, Davies JNP, Polan AK, et al. Familial Hodgkin's disease: an environmental and genetic disorder. Lancet 1974; ii: 854-857.
113. Svejgaard A, Platz P, Ryder LP, et al. HL-A and disease associations - a survey. Transplant Rev 1975; 22: 3-43.
114. Bodmer WF. Genetic factors in Hodgkin's disease: association with a disease-susceptibility locus (DSA) in the HL-A region. Natl Cancer Inst Monogr 1973; 36: 127-134.
115. Marshall WH, Barnard JM, Buehler SK, et al. HLA in familial Hodgkin's disease. Results and a new hypothesis. Int J Cancer 1977; 19: 450-455.
116. Hors J, Dausset J. HLA and susceptibility to Hodgkin's disease. Immunol Rev 1983; 70: 167-192.
117. Berberich FR, Berberich MS, King MC, et al. Hodgkin's disease susceptibility: linkage to the HLA locus demonstrated by a new concordance method. Hum Immunol 1983; 6: 207-217.
118. Greene MH, McKeen EA, Li FP, et al. HLA antigens in familial Hodgkin's disease. Int J Cancer 1979; 23: 777-780.
119. Shibuya H, Tsukada K, Takagi M, et al. Synchronous Hodgkin's disease in monozygotic twins. Acta Radiol Oncol 1984; 23: 425-428.
120. Chakravarti A, Halloran SL, Bale SJ, et al. Etiological heterogeneity in Hodgkin's disease: HLA linked and unlinked determinants of susceptibility independent of histological concordance. Genet Epidemiol 1986; 3: 407-415.
121. Mack TM, Cozen W, Shibata DK, et al. Concordance for Hodgkin's disease in identical twins suggesting genetic susceptibility to the young-adult form of the disease. New Engl J Med 1995; 332: 413-418.
122. Belkaid MI, Briere J, Djebbara Z, et al. Comparison of Epstein-Barr virus markers in Reed-Sternberg cells in adult Hodgkin's disease tissues from an industrialized and a developing country. Leuk Lymph 1995; 17: 163-168.
123. Leoncini L, Spina D, Nyong'o A, et al. Neoplastic cells of Hodgkin's disease show differences in EBV expression between Kenya and Italy. Int J Cancer 1996; 65: 781-784.
124. Weinreb M, Day PJ, Niggli F, et al. The consistent association between Epstein-Barr virus and Hodgkin's disease in children in Kenya. Blood 1996; 87: 3828-3836.
125. Kusuda M, Toriyama K, Kamidigo NO, et al. A comparison of epidemiologic, histologic, and virologic studies on Hodgkin's disease in western Kenya and Nagasaki, Japan. Am J Trop Med Hyg 1998; 59: 801-807.
126. Zhou XG, Hamilton-Dutoit SJ, Yan QH, et al. The association between Epstein-Barr virus and Chinese Hodgkin's disease. Int J Cancer 1993; 55: 359-363.
127. Park CS, Juhng SW, Brigati DJ, et al. Analysis of Epstein-Barr virus in Hodgkin's disease: experience of a single university hospital in Korea. J Clin Lab Anal 1994; 8: 412-417.
128. Chan JK, Yip TT, Tsang WY, et al. Detection of Epstein-Barr virus in Hodgkin's disease occurring in an Oriental population. Hum Pathol 1995; 26: 314-318.
129. Paulino AF, Paulino-Cabrera E, Weiss LM, et al. Hodgkin's disease in the Philippines. Mod Pathol 1996; 9: 115-119.
130. Tomita Y, Ohsawa M, Kanno H, et al. Epstein-Barr virus in Hodgkin's disease patients in Japan. Cancer 1996; 77: 186-192.
131. Peh SC, Looi LM, Pallesen G. Epstein-Barr virus (EBV) and Hodgkin's disease in a multi-ethnic population in Malaysia. Histopathology 1997; 30: 227-233.
132. Chang KL, Albujar PF, Chen YY, et al. High prevalence of Epstein-Barr virus in the Reed-Sternberg cells of Hodgkin's disease occurring in Peru. Blood 1993; 81: 496-501.
133. Quintanilla-Martinez L, Gamboa-Dominguez A, Gamez-Ledesma I, et al. (High prevalence of the Epstein-Barr virus in a Mexican population with Hodgkin's disease). Rev Invest Clin 1994; 46: 355-362.
134. Zarate-Osorno A, Roman LN, Kingma DW, et al. Hodgkin's disease in Mexico. Prevalence of Epstein-Barr virus sequences and correlations with histologic subtype. Cancer 1995; 75: 1360-1366.
135. Herbst H, Dallenbach F, Hummel M, et al. Epstein-Barr virus latent membrane protein expression in Hodgkin and Reed-Sternberg cells. Proc Natl Acad Sci USA 1991; 88: 4766-4770.
136. Pallesen G, Hamilton-Dutoit SJ, Rowe M, et al. Expression of Epstein-Barr virus latent gene products in tumour cells of Hodgkin's disease. Lancet 1991; 337: 320-322.
137. Delsol G, Brousset P, Chittal S, et al. Correlation of the expression of Epstein-Barr virus latent membrane protein and in situ hybridization with biotinylated BamHI-W probes in Hodgkin's disease. Am J Pathol 1992; 140: 247-253.
138. Herbst H, Steinbrecher E, Niedobitek G, et al. Distribution and phenotype of Epstein-Barr virus-harboring cells in Hodgkin's disease. Blood 1992; 80: 484-491.
139. Hummel M, Anagnostopoulos I, Dallenbach F, et al. EBV infection patterns in Hodgkin's disease and normal lymphoid tissue: expression and cellular localization of EBV gene products. Br J Haematol 1992; 82: 689-694.
140. Murray PG, Young LS, Rowe M, et al. Immunohistochemical demonstration of the Epstein-Barr virus-encoded latent membrane protein in paraffin sections of Hodgkin's disease. J Pathol 1992; 166: 1-5.
141. Carbone A, Gloghini A, Zanette I, et al. Co-expression of Epstein-Barr virus latent membrane protein and vimentin in 'aggressive' histological subtypes of Hodgkin's disease. Virch Arch A Pathol Anat Histopathol 1993; 422: 39-45.
142. Kanavaros P, Jiwa M, van d V, Walboomers J, et al. Expression of Epstein-Barr virus latent gene products and related cellular activation and adhesion molecules in Hodgkin's disease and non-Hodgkin's lymphomas arising in patients without overt pre-existing immunodeficiency. Hum Pathol 1993; 24: 725-729.
143. Niedobitek G, Rowlands DC, Young LS, et al. Overexpression of p53 in Hodgkin's disease: lack of correlation with Epstein-Barr virus infection. J Pathol 1993; 169: 207-212.
144. Lauritzen AF, Hording U, Nielsen HW. Epstein-Barr virus and Hodgkin's disease: a comparative immunological, in situ hybridization, and polymerase chain reaction study. APMIS 1994; 102: 495-500.
145. van Gorp J, Jacobse KC, Broekhuizen R, et al. Encoded latent membrane protein 1 of Epstein-Barr virus on follicular dendritic cells in residual germinal centres in Hodgkin's disease. J Clin Pathol 1994; 47: 29-32.
146. Jarrett AF, Armstrong AA, Alexander E. Epidemiology of EBV and Hodgkin's lymphoma. Ann Oncol 1996; 7(Suppl. 4): 5-10.
147. Enblad G, Sandvej K, Sundstrom C, et al. Epstein-Barr virus distribution in Hodgkin's disease in an unselected Swedish population. Acta Oncol 1999; 38: 425-429.
148. Weiss LM, Chen YY, Liu XF, et al. Epstein-Barr virus and Hodgkin's disease. A correlative in situ hybridization and polymerase chain reaction study. Am J Pathol 1991; 139: 1259-1265.
149. Pinkus GS, Lones M, Shintaku IP, et al. Immunohistochemical detection of Epstein-Barr virus-encoded latent membrane protein in Reed-Sternberg cells and variants of Hodgkin's disease. Mod Pathol 1994; 7: 454-461.
150. Poppema S, Visser L. Epstein-Barr virus positivity in Hodgkin's disease does not correlate with an HLA A2-negative phenotype. Cancer 1994; 73: 3059-3063.
151. Armstrong AA, Alexander FE, Paes RP, et al. Association of Epstein-Barr virus with pediatric Hodgkin's disease. Am J Pathol 1993; 142: 1683-1688.
152. Li PJ, Zhou XG, Liu SR. (The association of Epstein-Barr virus with Hodgkin's lymphoma in childhood). Zhonghua Bing Li Xue Za Zhi 1994; 23: 224-226.
153. Ambinder RF, Browning PJ, Lorenzana I, et al. Epstein-Barr virus and childhood Hodgkin's disease in Honduras and the United States. Blood 1993; 81: 462-467.
154. Preciado MV, De Matteo E, Diez B, et al. Presence of Epstein-Barr virus and strain type assignment in Argentine childhood Hodgkin's disease. Blood 1995; 86: 3922-3929.
155. Razzouk BI, Gan YJ, Mendonca C, et al. Epstein-Barr virus in pediatric Hodgkin disease: age and histio-type are more predictive than geographic region. Med Pediatr Oncol 1997; 28: 248-254.
156. Weinreb M, Day PJ, Murray PG, et al. Epstein-Barr virus (EBV) and Hodgkin's disease in children: incidence of EBV latent membrane protein in malignant cells. J Pathol 1992; 168: 365-369.
157. Brousset P, Rochaix P, Chittal S, et al. High incidence of Epstein-Barr virus detection in Hodgkin's disease and absence of detection in anaplastic large-cell lymphoma in children. Histopathology 1993; 23: 189-191.
158. Kanavaros P, Sakalidou A, Tzardi M, et al. Frequent detection of Epstein-Barr virus (EBV), EBER transcripts and latent membrane protein-1 (LMP-1) in tumor cells in Hodgkin's disease arising in childhood. Pathol Res Pract 1994; 190: 1026-1030.